Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Henrik Lindman

Professor

Uppsala University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Articles (20)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (43)

Mikael Åberg

Associate professor

Uppsala University

SWEDEN

View details

Fredrik Piehl

Karolinska Institutet

SWEDEN

View details

Jochen M Schwenk

KTH Royal Institute of Technology

SWEDEN

View details

Janice M. Walshe

Professor in Medical Oncology

St. Vincent's University Hospital

IRELAND

View details

Mattias Svensson

Researcher, Group Leader, Project Leader and Manager

Karolinska University Hospital

SWEDEN

View details

Martin Hoglund

Associate Professor

Uppsala Universitet Medicinska fakulteten

SWEDEN

View details

Mujdat Zeybel

Professor and Consultant Gastroenterologist

Koç University

TURKEY

View details

Ingrid Lundberg

Professor

Karolinska Institutet

SWEDEN

View details

Lakshmikanth Tadepally

Mass Cytometry Facility Head

Karolinska Institutet

SWEDEN

View details

Ioannis Zerdes

Karolinska University Hospital

SWEDEN

View details

Antti Siika

Karolinska Institutet

SWEDEN

View details

Piotr Nowak

Karolinska University Hospital

SWEDEN

View details

Jakob Woessmann

Technical University of Denmark

DENMARK

View details

Marie Wahren-Herlenius

Professor

Karolinska Institutet

SWEDEN

View details

Aglaia Schiza

Associate Professor (Docent, non-tenured and unsalaried title in the Swedish system)

Uppsala University

SWEDEN

View details

Andreas Hober

Karolinska Institutet

SWEDEN

View details

Tobias Sjöblom

Professor at Uppsala University

Uppsala University

SWEDEN

View details

Marie Holmqvist

Karolinska University Hospital

SWEDEN

View details

Karin Gunnarsson

Karolinska University Hospital

SWEDEN

View details

Erik Melén

Professor

Karolinska Institutet

SWEDEN

View details

Nikos Tsiknakis

Karolinska Institutet

SWEDEN

View details

Kristoffer Strålin

Karolinska Institutet

SWEDEN

View details

Per Oksvold

KTH Royal Institute of Technology

SWEDEN

View details

Linn Fagerberg

KTH Royal Institute of Technology

SWEDEN

View details

Antonis Valachis

Örebro university

SWEDEN

View details

Maria Ekholm

MD, PhD, Associate professor

Linköping University

SWEDEN

View details

Laura Biganzoli

Azienda Usl Toscana Centro

ITALY

View details

Iva Gunnarsson

professor, senior consultant in Rheumatology

Karolinska Institutet

SWEDEN

View details

Balazs Acs

Associate Professor

Karolinska Institutet

SWEDEN

View details

Göran Bergström

University of Gothenburg

SWEDEN

View details

Luís Costa

Universidade Católica Portuguesa

PORTUGAL

View details

Jacob Odeberg

KTH Royal Institute of Technology

SWEDEN

View details

Maria Jesus Iglesias Mareque

KTH Royal Institute of Technology

SWEDEN

View details

Luis Teixeira

Université Paris Cité

FRANCE

View details

Johan Hartman

Professor at Karolinska Institutet

Karolinska Institutet

SWEDEN

View details

Pirkko-Liisa Kellokumpu-Lehtinen

Professor of Radiotherapy and Oncology, emerita

Tampere University

FINLAND

View details

Sofia Bergström

KTH Royal Institute of Technology

SWEDEN

View details

Máté Szilcz

Karolinska Institutet

SWEDEN

View details

Jessica Nordlund

Associate Professor & Research Group Leader at Uppsala University

Uppsala University

SWEDEN

View details

Miklós Lipcsey

Uppsala University

SWEDEN

View details

Anton Reepalu

Docent (associate professor)

Lund University

SWEDEN

View details

Wen Zhong

Associate Professor

Linköping University

SWEDEN

View details

Jan Mulder

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Henrik Lindman

Research Interests

Explore related searches

Articles (20)

Risk Factors for Disease Recurrence in Patients with HER2+ Early Breast Cancer and Implications for Therapy: A Narrative Review

Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)

A human pan-disease blood atlas of the circulating proteome

Optimization of guidelines for Risk Of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter study

Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting.

Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients

Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer

The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial.

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer.

AAV‐mouse DNase I sustains long‐term DNase I expression in vivo and suppresses breast cancer metastasis

Lessons learned from an unsuccessful decentralized clinical trial in Oncology.

Effects of heavy-load strength training during (neo-)adjuvant chemotherapy on muscle strength, muscle fiber size, myonuclei, and satellite cells in women with breast cancer.

Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial.

Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study.

Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry.

Endocrine treatment near the end of life among older women with metastatic breast cancer: a nationwide cohort study

Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project.

Current treatment landscape of HR+/HER2- advanced breast cancer in the Nordics: a modified Delphi study.

Collaborators (43)

Mikael Åberg

Fredrik Piehl

Jochen M Schwenk

Janice M. Walshe

Mattias Svensson

Martin Hoglund

Mujdat Zeybel

Ingrid Lundberg

Lakshmikanth Tadepally

Ioannis Zerdes

Antti Siika

Piotr Nowak

Jakob Woessmann

Marie Wahren-Herlenius

Aglaia Schiza

Andreas Hober

Tobias Sjöblom

Marie Holmqvist

Karin Gunnarsson

Erik Melén

Nikos Tsiknakis

Kristoffer Strålin

Per Oksvold

Linn Fagerberg

Antonis Valachis

Maria Ekholm

Laura Biganzoli

Iva Gunnarsson

Balazs Acs

Göran Bergström

Luís Costa

Jacob Odeberg

Maria Jesus Iglesias Mareque

Luis Teixeira

Johan Hartman

Pirkko-Liisa Kellokumpu-Lehtinen

Sofia Bergström

Máté Szilcz

Jessica Nordlund

Miklós Lipcsey

Anton Reepalu

Wen Zhong

Jan Mulder

Make your next move.